Please assess the completion status of the following clinical trial:

Trial Title: Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* FOR THE MAIN TRIAL, NN5401-3594:~* Type 1 diabetes mellitus for at least 12 months~* Ongoing daily treatment with insulin (in a basal bolus regimen, premix insulin regimen, self mix regimen) for at least 12 months~* HbA1c 7.0-10.0% (both inclusive)~* BMI (Body Mass Index) below or equal to 35.0 kg/m\^2~* FOR THE EXTENSION TRIAL, NN5401-3645:~* The subject must have completed the six-month treatment period in trial NN5401-3594~Exclusion Criteria:~* FOR THE MAIN TRIAL, NN5401-3594:~* Treatment with other insulin regimens than insulin in a basal bolus regimen/premix insulin regimen/self mix regimen within 3 months~* Cardiovascular disease within the last 6 months~* Uncontrolled treated/untreated severe hypertension~* Pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures according to local requirements~* Cancer and medical history of cancer~* FOR THE EXTENSION TRIAL, NN5401-3645:~* Anticipated significant lifestyle changes during the trial~* Pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IDegAsp OD (Type: EXPERIMENTAL): None
- IDet (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).